{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:04:57Z","timestamp":1767474297175,"version":"3.40.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Idiopathic hypertrophic pachymeningitis (IHP) is a rare neurological disorder without a definite etiology. Diagnosis is mainly based on exclusion of other etiologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 41-year-old male patient presented with insidious onset headache of 3-month duration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Contrast-enhanced brain magnetic resonance imaging (MRI) revealed diffuse pachymeningeal enhancement over bilateral cerebral hemispheres and the tentorium cerebelli. Lumbar puncture showed increased pressure, lymphocytic pleocytosis, and elevated protein level with normal glucose concentration. Blood tests detected elevated erythrocyte sedimentation rate (ESR) and C-reactive protein. Pathological examination of the dura mater from the right frontal convexity disclosed coarse collagenous deposition with focal lymphoid aggregation. After malignancy and infectious etiologies were excluded, a diagnosis of IHP was made.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Oral prednisolone and azathioprine followed by methotrexate were administered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>During the 7-year follow-up period, although the patient was not totally headache-free, medical therapy significantly reduced the severity of headache. Follow-up MRI studies showed a reduction in meningeal enhancement and serial ESR measurements revealed a trend of improvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Methotrexate therapy may be considered in cases of steroid-resistant IHP. In addition to clinical evaluation, serial ESR testing may be considered to guide the treatment strategy and assess the response to therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024387","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:12:21Z","timestamp":1610640741000},"page":"e24387","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody"],"prefix":"10.1097","volume":"100","author":[{"given":"Chi-Shun","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-8813","authenticated-orcid":false,"given":"Sheng-Feng","family":"Sung","sequence":"additional","affiliation":[{"name":"Division of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jocn.2013.09.025","article-title":"Idiopathic hypertrophic pachymeningitis: clinical, laboratory and neuroradiologic features in China","volume":"21","author":"Zhao","year":"2014","journal-title":"J Clin Neurosci"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/01.WNL.0000113748.53023.B7","article-title":"Idiopathic hypertrophic pachymeningitis","volume":"62","author":"Kupersmith","year":"2004","journal-title":"Neurology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2014","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1526-4610.2004.04175.x","article-title":"Headache profile in patients with idiopathic hypertrophic cranial pachymeningitis","volume":"44","author":"Wang","year":"2004","journal-title":"Headache"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0929-6646(08)60132-1","article-title":"Focal idiopathic hypertrophic pachymeningoencephalitis","volume":"107","author":"Lu","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"R6-20250504","first-page":"127","article-title":"Idiopathic hypertrophic cranial pachymeningitis","volume":"13","author":"Hamilton","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00296-007-0504-5","article-title":"Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature","volume":"28","author":"Bosman","year":"2008","journal-title":"Rheumatol Int"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.radcr.2019.07.005","article-title":"Spontaneous intracranial hypotension in a patient with systemic lupus erythematosus","volume":"14","author":"Cohen-Addad","year":"2019","journal-title":"Radiol Case Rep"},{"key":"R9-20250504","first-page":"43","article-title":"Magnetic resonance imaging findings in tuberculous meningoencephalitis","volume":"52","author":"Pui","year":"2001","journal-title":"Can Assoc Radiol J"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00234-019-02215-y","article-title":"Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?","volume":"61","author":"Bier","year":"2019","journal-title":"Neuroradiology"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clineuro.2018.02.035","article-title":"Marked effectiveness of low-dose oral methotrexate for steroid-resistant idiopathic hypertrophic pachymeningitis: case report","volume":"168","author":"Uchida","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2012.05.006","article-title":"Secondary hypertrophic pachymeningitis in antiphospholipid syndrome","volume":"250","author":"Tokushige","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.msard.2019.01.026","article-title":"Pachymeningitis with optic neuropathy associated with extrapulmonary tuberculosis and secondary antiphospholipid syndrome","volume":"29","author":"De Stefano","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10072-018-3689-3","article-title":"Clinical features of hypertrophic pachymeningitis in a center survey","volume":"40","author":"Ca\u00e7\u00e3o","year":"2019","journal-title":"Neurol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","author":"Lu","year":"2014","journal-title":"JAMA Neurol V 71"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jamaneurol.2013.3950","article-title":"Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexate","volume":"71","author":"Hyun","year":"2014","journal-title":"JAMA Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:24:09Z","timestamp":1746339849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024387"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024387","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"2020-10-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}